Pharmacist-led medication management program within a patient-centered medical home

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Robert J RomanelliDenis Y Ishisaka

Abstract

The impact of a clinical pharmacist-led medication management program (MMP) within a patient-centered medical home (PCMH) was evaluated. This retrospective analysis included patients in Sutter Health's electronic health records who (1) were seen by the MMP clinical pharmacist within the PCMH (MMP cohort), (2) were within the PCMH but were not referred to the MMP pharmacist (PCMH cohort), or (3) received usual care at two non-PCMH primary care clinics (usual care cohort). Patients were matched on their propensity for receiving medication management. The primary outcome measure was healthcare resource use (i.e., ambulatory care visits, emergency department [ED] visits, and hospitalizations). MMP patients had a higher percentage of ambulatory care visits relative to PCMH patients (p = 0.004) but a lower rate of hospitalizations (p = 0.003). The MMP group had a lower frequency of hospitalizations (p < 0.001) and ED visits (p = 0.014) relative to patients in the usual care group. No differences in healthcare resource use were observed between the PCMH and usual care cohorts. Glycosylated hemoglobin, blood pressure, or low-density-lipoprotein cholesterol at goal did not significantly differ among the three cohorts. Patients in a phar...Continue Reading

References

Aug 1, 1993·Journal of the American College of Cardiology·E D Frohlich
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jan 15, 2008·Journal of the American Pharmacists Association : JAPhA·Barry A BuntingSusan E Sutherland
Mar 25, 2008·Journal of the American Pharmacists Association : JAPhA·Brian J IsettsRobert J Cipolle
Mar 18, 2009·Journal of the American Pharmacists Association : JAPhA·Lourdes G PlanasKevin C Farmer
Nov 26, 2009·Archives of Internal Medicine·Barry L CarterYinghui Xu
May 5, 2010·Health Affairs·Marie SmithPaul D Cleary
Dec 2, 2010·The Annals of Pharmacotherapy·Kathleen A JohnsonJeffrey McCombs
Mar 9, 2011·Journal of the American Pharmacists Association : JAPhA·Steven Erickson, Jeffrey Hambleton
Mar 9, 2011·Journal of the American Pharmacists Association : JAPhA·Mollie Ashe ScottGaye Colvin
Mar 9, 2011·Journal of the American Pharmacists Association : JAPhA·Leticia R MoczygembaGary R Matzke
May 31, 2012·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Hae Mi ChoeConnie J Standiford
Jun 9, 2012·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Heather D EdwardsBecky L Armor
Oct 2, 2012·Journal of the American Pharmacists Association : JAPhA·Hildegarde J Berdine, Monica L Skomo
Jan 4, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Feb 6, 2013·Cardiorenal Medicine·Lauren Odum, Adam Whaley-Connell
Jun 22, 2013·Statistics in Medicine·Erinn M Hade, Bo Lu
Apr 9, 2014·BMC Family Practice·Sandra H van OostromCaroline A Baan

❮ Previous
Next ❯

Citations

Mar 5, 2016·Drugs & Aging·Jeannell M Mansur
Oct 12, 2018·Journal of the American Geriatrics Society·Leah B HerityAnna P Schenck
Sep 10, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Antoinette B Coe, Hae Mi Choe
Mar 17, 2020·Journal of Primary Health Care·Robert HauaTrudi Aspden

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.